Endo Pharmacauticals has discontinued XIAFLEX injection in Australia and Asia,
Endo Pharmacauticals has discontinued XIAFLEX ,Collagenase Clostridium Histolyticum (CCH) injection in Australia and Asia, and plans to do the same to whole Europe by the end of 2019. The American laboratory has decided to withdraw it for economic reasons.
Endo Pharmacauticals has discontinued XIAFLEX ,Collagenase Clostridium Histolyticum (CCH) injection in Australia and Asia, and plans to do the same to whole Europe by the end of 2019. The American laboratory has decided to withdraw it for economic reasons.